Filing Details
CNBX Pharmaceuticals Inc. (OTC:CNBX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on June 24, 2026.
The Healthcare company reported Q0 revenue of .
10q filedOTC:CNBX
CNBX Pharmaceuticals Inc. (CNBX) Files Quarterly Report for Q0
Filing Details CNBX Pharmaceuticals Inc. (OTC:CNBX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on June 24, 2026. The Healthcare company…
Market Context
CNBX Pharmaceuticals Inc.'s stock currently trades at $0.00 with a market capitalization of $37.0K.
The 10-Q provides CNBX Pharmaceuticals Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CNBX Pharmaceuticals Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CNBX Stock Page
Frequently Asked Questions
Where can I read CNBX's SEC filings?
Browse all filings on our CNBX SEC filings page.
What types of SEC filings does CNBX Pharmaceuticals Inc. file?
Public companies like CNBX Pharmaceuticals Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.